Published • loading... • Updated
Preparing for Next Threat, Korea Advances Own mRNA Vaccine
Summary by The Korea Times
2 Articles
2 Articles
Preparing for next threat, Korea advances own mRNA vaccine
With the COVID-19 pandemic exposing the critical need for domestic vaccine production, Korea signaled Friday that it intends to be among the nations capable of addressing this necessity, advancing a homegrown messenger RNA (mRNA) vaccine candidate into Phase II clinical trials. The Korea Disease Control and Prevention Agency (KDCA) and the National Institute of Health said pharmaceutical giant GC Biopharma submitted its Phase II trial plan to re…
·Seoul, Korea (the Republic of)
Read Full Article
(Seoul = Yonhap News) Reporter Kim Jan-di = GC Green Cross is moving forward with a full-scale Phase 2 clinical trial of a domestically produced messenger ribonucleic acid (mRNA) vaccine for the prevention of COVID-19.
·Seoul, Korea (the Republic of)
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right1Center0Last UpdatedBias Distribution50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
